A detailed history of Evelyn Partners Asset Management LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Evelyn Partners Asset Management LTD holds 417 shares of ABT stock, worth $54,222. This represents 0.01% of its overall portfolio holdings.

Number of Shares
417
Previous 286 45.8%
Holding current value
$54,222
Previous $38.9 Million 43.58%
% of portfolio
0.01%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$120.51 - $136.62 $15,786 - $17,897
131 Added 45.8%
417 $55.9 Million
Q2 2025

Aug 12, 2025

SELL
$123.95 - $138.08 $2.83 Million - $3.15 Million
-22,796 Reduced 98.76%
286 $38.9 Million
Q1 2025

Aug 04, 2025

BUY
$111.1 - $140.22 $2.56 Million - $3.24 Million
23,082 New
23,082 $37.9 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Evelyn Partners Asset Management LTD Portfolio

Follow Evelyn Partners Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evelyn Partners Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Evelyn Partners Asset Management LTD with notifications on news.